4-(tert-butoxy)-3-chloroaniline | 1039334-68-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 4-(tert-butoxy)-3-chloroaniline
• 英文别名: 3-chloro-4-[(2-methylpropan-2-yl)oxy]aniline
• CAS: 1039334-68-3
• 化学式: C₁₀H₁₄ClNO
• 分子量: 199.68
• InChiKey: UUXBZGOILICMAR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-(tert-butoxy)-3-chloroaniline 在 水 、 2,3-二氯-5,6-二氰基-1,4-苯醌 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 0.5h， 生成 1-[3-chloro-4-[(2-methylpropan-2-yl)oxy]-N-prop-2-ynoylanilino]cyclopentane-1-carboxamide
  参考文献：
  名称：

  [EN] GPX4 INHIBITORS AND USE THEREOF
  [FR] INHIBITEURS DE GPX4 ET LEUR UTILISATION

  摘要：

  The present disclosure provides a compound of Formula (I'), or a pharmaceutically acceptable salt thereof and its use in, e.g. treating a condition, disease, or disorder in which inhibiting GPX4 in a subject is of therapeutic benefit, specifically in treating cancer or autoimmune diseases. This disclosure also features a composition containing the same as well as methods of using and making the same.

  公开号：

  WO2024030651A1
• 作为产物：
  描述：

  2-chloro-4-nitrophenyl-tert-butyl ether 在 ammonium hydroxide 、 铁粉 作用下， 以 乙醇 为溶剂， 生成 4-(tert-butoxy)-3-chloroaniline
  参考文献：
  名称：

  [EN] GPX4 INHIBITORS AND USE THEREOF
  [FR] INHIBITEURS DE GPX4 ET LEUR UTILISATION

  摘要：

  The present disclosure provides a compound of Formula (I'), or a pharmaceutically acceptable salt thereof and its use in, e.g. treating a condition, disease, or disorder in which inhibiting GPX4 in a subject is of therapeutic benefit, specifically in treating cancer or autoimmune diseases. This disclosure also features a composition containing the same as well as methods of using and making the same.

  公开号：

  WO2024030651A1

文献信息

• METHOD FOR PRODUCING BIARYL COMPOUND
  申请人：Sato Koichi

  公开号：US20100087680A1

  公开（公告）日：2010-04-08

  A method for producing a biaryl compound, comprising reacting an aromatic organic compound with at least one compound selected from the group consisting of aromatic organoboron compounds and boroxine compounds, in the presence of a zero-valent nickel catalyst, phosphine ligand and base.

  一种制备双芳基化合物的方法，包括在零价镍催化剂、膦配体和碱的存在下，将芳香有机化合物与选自芳香基有机硼化合物和硼氧化物化合物组的至少一种化合物反应。
• PROCESS FOR PRODUCING BIARYL COMPOUND
  申请人：Sumitomo Chemical Company, Limited

  公开号：EP1914221A1

  公开（公告）日：2008-04-23

  A method for producing a biaryl compound, comprising reacting an aromatic organic compound with at least one compound selected from the group consisting of aromatic organoboron compounds and boroxine compounds, in the presence of a zero-valent nickel catalyst, phosphine ligand and base.

  一种生产双芳基化合物的方法，包括在零价镍催化剂、膦配体和碱存在下，使芳香族有机化合物与至少一种选自由芳香族有机硼化合物和硼氧化合物组成的组中的化合物反应。
• ACRYLANILIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF IN PHARMACY
  申请人：Ancureall Pharmaceutical (Shanghai) Co., Ltd.

  公开号：EP3398939A1

  公开（公告）日：2018-11-07

  Disclosed in the present invention are an acrylanilide compound represented by general formula (I) and a pharmaceutically acceptable salt thereof. The acrylanilide compound and the pharmaceutically acceptable salt thereof are used for treating clinical diseases by mainly acting on EGFR family casein kinases.

  本发明公开了一种由通式（I）代表的丙烯酰苯胺化合物及其药学上可接受的盐。该丙烯酰苯胺化合物及其药学上可接受的盐主要作用于表皮生长因子受体家族的酪蛋白激酶，用于治疗临床疾病。
• Acrylanilide derivative, preparation method, and applications thereof in pharmacy
  申请人：Ancureall Pharmaceutical (Shanghai) Co., Ltd.

  公开号：US10342796B2

  公开（公告）日：2019-07-09

  Disclosed in the present invention are an acrylanilide compound represented by general formula (I) and a pharmaceutically acceptable salt thereof. The acrylanilide compound and the pharmaceutically acceptable salt thereof are used for treating clinical diseases by mainly acting on EGFR family casein kinases.

  本发明公开了一种由通式（I）代表的丙烯酰苯胺化合物及其药学上可接受的盐。丙烯酰苯胺化合物及其药学上可接受的盐主要通过作用于表皮生长因子受体（EGFR）家族酪蛋白激酶来治疗临床疾病。
• [EN] ACRYLANILIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF IN PHARMACY<br/>[FR] DÉRIVÉ D'ACRYLANILIDE, SON PROCÉDÉ DE PRÉPARATION ET SES APPLICATIONS EN PHARMACIE<br/>[ZH] 丙烯酰苯胺衍生物、其制备方法及其药学上的应用
  申请人：ANCUREALL PHARMACEUTICAL (SHANGHAI) CO LTD

  公开号：WO2017114500A1

  公开（公告）日：2017-07-06

  本发明公开了下述通式（I）所示的丙烯酰苯胺类化合物及其药学上可接受的盐。该化合物或其药学上可接受的盐主要通过作用于EGFR家族酪蛋白激酶从而用于治疗临床疾病。